Erliso Injection
Marketer
Wockhardt Ltd
Salt Composition
Terlipressin (1mg)
Overview Erliso Injection
Vasopressin injection, a medication for managing hemorrhage from enlarged esophageal veins, constricts blood vessels to reduce blood flow in affected areas. Administered solely by medical professionals, it's reserved for cases of severe or life-threatening esophageal bleeding. Dosage and frequency are determined by your physician; self-administration is strictly prohibited. Potential side effects include headache, bradycardia, hypertension, peripheral vasoconstriction, and potentially peripheral ischemia or hypotension. Persistent or worsening side effects require immediate medical attention. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and provide a complete list of all current medications. This treatment is not indicated for pediatric or adolescent patients.
Primary Ingredients of Erliso Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Erliso Injection
Life-threatening esophageal vein hemorrhage
Major Benefits of Erliso Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Erliso Injection:
- Headache
- Slow heart rate
- Abdominal cramp
- Diarrhea
- High blood pressure
- Peripheral ischemia
- Vasoconstriction of the extremities
How to use Erliso Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Erliso Injection works:
Erliso Injection constricts blood vessel walls, reducing blood flow to affected veins, thereby controlling or halting hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erliso Injection may pose unknown risks. Physician consultation is advised.
PregnancyUNSAFE
Administering Erliso Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in animal and human studies has revealed considerable harm to the fetus.
Breast feedingCONSULT YOUR DOCTOR
Data on Erliso Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Erliso Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Erliso Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Erliso Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Erliso Injection :
Omit any missed dose of Erliso Injection and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Erliso Injection
| Label | Value |
|---|---|
| Chemical Type | Synthetic vasopressin |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Action Class | Synthetic vasopressin |
3,018 People bought this recently